|
| | Publication Year | Title | Author(s) |
| 41 | 29-Jan-2021 | Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study. | Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C |
| 42 | 1-Jan-2021 | Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD. | Schmoll, Hans-Joachim; Stein, Alexander; Van Cutsem, Eric; Price, Timothy; Hofheinz, Ralf D; Nordlinger, Bernard; Daisne, Jean-François; Janssens, Jos; Brenner, Baruch; Reinel, Hans; Hollerbach, Stephan; Caca, Karel; Fauth, Florian; Hannig, Carla V; Zalcberg, John; Tebbutt, Niall C ; Mauer, Murielle E; Marreaud, Sandrine; Lutz, Manfred P; Haustermans, Karin |
| 43 | 2021 | Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials Group. | Dunn, Catherine; Hong, Wei; Gibbs, Peter; Ackland, Stephen; Sjoquist, Katrin; Tebbutt, Niall C ; Price, Timothy; Burge, Matthew |
| 44 | 1-Nov-2020 | Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA. | Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; Gramont, Aimery De; Shi, Qian; Overman, Michael James |
| 45 | 1-Sep-2020 | Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial. | Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Jackett, Louise A ; Lum, Caroline; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S |
| 46 | 20-Apr-2020 | Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. | Roy, Amitesh C; Shapiro, Jeremy; Burge, Matt; Karapetis, Christos S; Pavlakis, Nick; Segelov, Eva; Chau, Ian; Lordick, Florian; Chen, Li-Tong; Barbour, Andrew; Tebbutt, Niall C ; Price, Tim |
| 47 | Apr-2020 | Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO Congress 2019. | Lau, David K ; Burge, Matthew; Roy, Amitesh; Chau, Ian; Haller, Daniel G; Shapiro, Jeremy D; Peeters, Marc; Pavlakis, Nick; Karapetis, Christos S; Tebbutt, Niall C ; Segelov, Eva; Price, Timothy J |
| 48 | 19-Mar-2020 | Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients with Elevated CEA. | Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; De Gramont, Aimery; Shi, Qian; Overman, Michael James |
| 49 | Mar-2020 | Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. | Williams, David S ; Mouradov, Dmitri; Browne, Clare; Palmieri, Michelle; Elliott, Meg J; Nightingale, Rebecca; Fang, Catherine G; Li, Rita; Mariadason, John M ; Faragher, Ian; Jones, Ian T; Churilov, Leonid ; Tebbutt, Niall C ; Gibbs, Peter; Sieber, Oliver M |
| 50 | 2020 | The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]. | Clarke, Stephen John; Burge, Matthew; Feeney, Kynan; Gibbs, Peter; Jones, Kristian; Marx, Gavin; Molloy, Mark P; Price, Timothy; Reece, William H H; Segelov, Eva; Tebbutt, Niall C |
| 51 | 22-Nov-2019 | Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets. | Lau, David K ; Mouradov, Dmitri; Wasenang, Wiphawan; Luk, Ian Y; Scott, Cameron M; Williams, David S ; Yeung, Yvonne H ; Limpaiboon, Temduang; Iatropoulos, George F ; Jenkins, Laura J; Reehorst, Camilla M; Chionh, Fiona; Nikfarjam, Mehrdad ; Croagh, Daniel; Dhillon, Amardeep S; Weickhardt, Andrew J ; Muramatsu, Toshihide; Saito, Yoshimasa; Tebbutt, Niall C ; Sieber, Oliver M; Mariadason, John M |
| 52 | 4-Sep-2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. | Burzykowski, Tomasz; Coart, Elisabeth; Saad, Everardo D; Shi, Qian; Sommeijer, Dirkje W; Bokemeyer, Carsten; Díaz-Rubio, Eduardo; Douillard, Jean-Yves; Falcone, Alfredo; Fuchs, Charles S; Goldberg, Richard M; Hecht, J Randolph; Hoff, Paulo M; Hurwitz, Herbert; Kabbinavar, Fairooz F; Koopman, Miriam; Maughan, Timothy S; Punt, Cornelis J A; Saltz, Leonard; Schmoll, Hans-Joachim; Seymour, Matthew T; Tebbutt, Niall C ; Tournigand, Christophe; Van Cutsem, Eric; de Gramont, Aimery; Zalcberg, John R; Buyse, Marc |
| 53 | Jun-2019 | Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial. | Tapia Rico, Gonzalo; Price, Timothy; Tebbutt, Niall C ; Hardingham, Jennifer; Lee, Chee; Buizen, Luke; Wilson, Kate; Gebski, Val; Townsend, Amanda |
| 54 | 16-Apr-2019 | Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. | Eng, Cathy; Kim, Tae Won; Bendell, Johanna; Argilés, Guillem; Tebbutt, Niall C ; Di Bartolomeo, Maria; Falcone, Alfredo; Fakih, Marwan; Kozloff, Mark; Segal, Neil H; Sobrero, Alberto; Yan, Yibing; Chang, Ilsung; Uyei, Anne; Roberts, Louise; Ciardiello, Fortunato |
| 55 | Apr-2019 | Systemic treatment of advanced hepatocellular cancer: new hope on the horizon. | Chang Lee, Rachael; Tebbutt, Niall C |
| 56 | Mar-2019 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christos; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 57 | Dec-2018 | Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. | Shapiro, Jeremy D; Thavaneswaran, Subotheni; Underhill, Craig R; Robledo, Kristy P; Karapetis, Christos S; Day, Fiona L; Nott, Louise M; Jefford, Michael; Chantrill, Lorraine A; Pavlakis, Nick; Tebbutt, Niall C ; Price, Timothy J; Khasraw, Mustafa; Van Hazel, Guy A; Waring, Paul M; Tejpar, Sabine; Simes, John; Gebski, Val J; Desai, Jayesh; Segelov, Eva |
| 58 | Dec-2018 | Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response. | Sud, S; O'Callaghan, C ; Jonker, C; Karapetis, C; Price, T; Tebbutt, Niall C ; Shapiro, J; Van Hazel, G; Pavlakis, N; Gibbs, P; Jeffrey, M; Siu, L; Gill, S; Wong, R ; Jonker, D; Tu, D; Goodwin, R |
| 59 | 28-Nov-2018 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christopher S; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 60 | 1-Nov-2018 | The prognostic impact of Consensus Molecular Subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial. | Mooi, Jennifer K ; Wirapati, P; Asher, R; Lee, C K; Savas, P S; Price, T J; Townsend, A; Hardingham, J; Buchanan, D; Williams, D ; Tejpar, S; Mariadason, John M ; Tebbutt, Niall C |
Loading...
2
0
20
0
false